Carolyn Jennifer Eden Belcher

Carolyn Jennifer Eden Belcher

Director Director DIN 07912227
DIN 07912227 First appointment Aug 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Aug 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Carolyn Jennifer Eden Belcher

Data last updated:

Carolyn Jennifer Eden Belcher was a Director at Pharmalex India Private Limited (2017–2023). The company operates in Healthcare.

DIN 07912227
Primary Designation Director
Industry Healthcare
First Appointment 25 Aug 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmalex India Private Limited U85100DL2013FTC252553
Director25 Aug 20172013₹74.75 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmalex India Private Limited
Premium access

Shareholding and investment profile for Carolyn Jennifer Eden Belcher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Carolyn Jennifer Eden Belcher

Carolyn Jennifer Eden Belcher was first appointed on 25 Aug 2017 as Director at Pharmalex India Private Limited.

Carolyn Jennifer Eden Belcher held 1 earlier board appointment: Pharmalex India Private Limited (Director, 25 Aug 2017 to 05 Sep 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available